4208:TSEUBE Corporation Analysis
Data as of 2026-03-17 - not real-time
¥2,526.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: UBE is trading at ¥2,526.5, below the 20‑day (¥2,717.8) and 50‑day (¥2,704.4) SMAs but still above the 200‑day SMA (¥2,429.9), indicating a longer‑term bullish bias yet short‑term weakness. The RSI sits at 37.8, edging toward oversold territory, while the MACD line remains well under its signal (‑51.3 vs ‑22.1) and the histogram is negative, signaling bearish momentum in the near term.
Fundamental picture: The company delivers modest revenue growth (2.5%) with thin margins (gross 22.7%, operating 5.1%). Valuation appears attractive on a value basis – price‑to‑book 0.58 and price‑to‑sales 0.53 – and the DCF suggests an 8% upside to ¥3,740. However, the trailing PE is lofty at 42.6, offset by a forward PE of 7.4 thanks to a sharp EPS lift. A high dividend yield of 4.36% is offset by an unsustainable payout ratio of 186%, and the balance sheet is strained with a debt‑to‑equity of 80 and negative free cash flow.
Risk & outlook: Volatility is elevated (≈38% 30‑day) but beta is low (≈0.46), tempering market‑wide risk. Leverage and cash‑flow deficits pose the primary downside, while the cheap book value, strong dividend yield (if normalized) and forward earnings growth provide upside catalysts toward the fair‑value target.
Fundamental picture: The company delivers modest revenue growth (2.5%) with thin margins (gross 22.7%, operating 5.1%). Valuation appears attractive on a value basis – price‑to‑book 0.58 and price‑to‑sales 0.53 – and the DCF suggests an 8% upside to ¥3,740. However, the trailing PE is lofty at 42.6, offset by a forward PE of 7.4 thanks to a sharp EPS lift. A high dividend yield of 4.36% is offset by an unsustainable payout ratio of 186%, and the balance sheet is strained with a debt‑to‑equity of 80 and negative free cash flow.
Risk & outlook: Volatility is elevated (≈38% 30‑day) but beta is low (≈0.46), tempering market‑wide risk. Leverage and cash‑flow deficits pose the primary downside, while the cheap book value, strong dividend yield (if normalized) and forward earnings growth provide upside catalysts toward the fair‑value target.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term SMAs
- bearish MACD and negative histogram
- oversold RSI suggesting limited downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward PE of 7.4 indicating earnings acceleration
- DCF upside of ~8% and cheap book value
- increasing volume supporting liquidity
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- high debt‑to‑equity and negative free cash flow
- unsustainable dividend payout ratio
- diversified product mix across chemicals and machinery
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin7.70%
P/E Ratio42.6
ROE8.76%
ROA1.64%
Debt/Equity80.05
P/B Ratio0.6
Op. Cash Flow¥62.9B
Free Cash Flow¥-33875499008
Technical Analysis
TrendBullish
RSI37.8
Support¥2,474.00
Resistance¥2,888.50
MA 20¥2,717.75
MA 50¥2,704.44
MA 200¥2,429.93
MACDBearish
VolumeIncreasing
Fear & Greed Index77.89
Valuation
Fair Value¥3,740.20
Target Price¥2,740.00
Upside/Downside8.45%
GradeUndervalued
TypeBlend
Dividend Yield4.36%
Risk Assessment
Beta0.46
Volatility37.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.